Ligand Pharmaceuticals LGND
NASDAQ LGND
$313.18 +2.82 (+0.91%)
As of: Sep 30, 2026 · 3:59 PM EDT

Ligand Pharmaceuticals (LGND) Debt Ratio (2011 - 2026)

Updated

Ligand Pharmaceuticals' (LGND) Debt Ratio was 0.52 for Q2 2026, up 76.7% from the prior quarter.

Analysis

Ligand Pharmaceuticals (LGND) Debt Ratio (2011 - 2026) Analysis & Trends

For FY2025, Debt Ratio at Ligand Pharmaceuticals was 0.29.

  • By year, Debt Ratio came in at 0.10 in FY2022.
  • The Q2 2026 figure ranks as the highest quarterly Debt Ratio since Q4 2015.
  • Per Business Quant data, the three quarters before Q2 2026 came in at 0.29 (Q1 2026), 0.29 (Q4 2025) and 0.30 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 0.24
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 0.52
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 0.42
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 0.31
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 0.00
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 0.60
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 0.53
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 0.31
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn -
10 Ligand Pharmaceuticals 6.18 Bn 2.65 Bn - 0.52
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.52
Mar 31, 2026 0.29
Dec 31, 2025 0.29
Sep 30, 2025 0.30
Mar 31, 2023 0.09
Dec 31, 2022 0.10
Sep 30, 2022 0.07
Jun 30, 2022 0.11
Jun 30, 2019 0.02
Mar 31, 2019 0.01
Dec 31, 2018 0.02
Sep 30, 2018 0.10
Jun 30, 2018 0.11
Mar 31, 2018 0.30
Dec 31, 2017 0.33
Sep 30, 2017 0.33
Jun 30, 2017 0.34
Mar 31, 2017 0.34
Dec 31, 2016 0.35
Jun 30, 2016 0.34
API Access

Ligand Pharmaceuticals Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=LGND&period=max&api_key=YOUR_API_KEY